Despite COVID-19 and the illnesses associated with vaping, industry experts report that sales are doing well and are primed to do better as the year progresses.
The vaping market was on the fast track until a strange pulmonary disease appeared in 2019 and threw everyone for a loop. Then came the new year, along with COVID-19, a respiratory illness that has most government officials asking people to wear masks and maintain social distance in order to prevent the spread. With this in mind, the use of vapes and cigarettes should be fizzling out, but experts don’t think that’s the case.
While most people know that smoking harms the lungs, a lot of people are still smoking marijuana as a way to cope with the stress of the virus and long hours of boredom. Smoking marijuana may cause lung irritation and chronic bronchitis but, unlike smoking cigarettes, it’s not associated with significant abnormalities in lung functioning. While there are obvious risks, people who smoke cigarettes are the ones who are dealing more harm to their lungs, especially since this act is likely repeated several times a day.
Vaping is generally associated with less lung damage. Still, experts warn about the unknown chemicals present in the cartridges. “If you’re using a vape pen, you’re taking some chances that there’s stuff other than pure cannabis oil in that cartridge,” internal medicine specialist Erick Kaufman tells The Cut. “We should all be really protective of our respiratory tracts right now, so it’s probably not a good time to be doing any inhaling of cannabis if you can help it.”
Photo by Lepro/Getty Images